GSK

The 7 Best ESG Stocks to Buy for the Biggest (Socially Responsible) Gains

By Josh Enomoto, InvestorPlace Contributor
While sustainable initiatives sound like a strategy for non-profit organizations, shifting demographics bode well for ESG stocks.

7 Pharmaceutical Stocks With Dividends in Hand

By Thomas Niel, InvestorPlace Contributor
So, which pharmaceutical stocks should be on your radar, if dividends are a top priority? Consider these seven compelling opportunities.

7 Cheap Stocks That Won’t Be on Discount for Long

By Faizan Farooque, InvestorPlace Contributor
Cheap, solid stocks may seem like a mirage considering the equity bull run, but several excellent investments are trading at a discount.

7 High-Yield Dividend Stocks With Enough Earnings to Cover the Dividends

By Mark R. Hake, CFA
These 7 high-yield dividend stocks have yields above 5% and their payout ratios broadly look strong enough to support those dividends.

VIR Stock: Why Vir Biotechnology Is Plunging Today

By Chris MacDonald, InvestorPlace Contributor
VIR stock is plunging on some pretty unfavorable news about a trial being suspended for the company's prospective Covid-19 vaccine.

7 Stocks to Sell for March

By Louis Navellier and the InvestorPlace Research Staff
The market is starting to get volatile again and sector rotation is underway. Clear the decks by dumping these stocks to sell for March.

10 Dividend Stocks Increasing Their Payouts 

By Will Ashworth, InvestorPlace Contributor
When it comes to investing in dividend stocks, companies that significantly increase their payouts are more attractive than those with higher yields.

The Best 4 Pharmaceutical Stocks to Buy in Any Climate

By Joel Baglole, InvestorPlace Contributor
Pharmaceutical stocks, such as Moderna and Novavaxsaw their share prices more than double in the last year. However, not all pharmaceutical stocks have their wagons hitched to solving the Covid-19 pandemic. There are many pharmaceutical stocks that are great long-term investments and would be good additions to a portfolio in any environment. Here we look at four such pharmaceutical stocks.

8 Dental Stocks If You Want to Clean Up

By Josh Enomoto, InvestorPlace Contributor
As the Covid-19 pandemic worsens, the case for dental stocks to buy might not seem too bright. However, this sector is a very broad one, with upside opportunities available right now.

The 7 Best Coronavirus Vaccine Stocks Still In The Race For A Cure

By Tezcan Gecgil, InvestorPlace Contributor
Buying strong vaccine stocks at the forefront of the scientific race to treat Covid-19 will help any long-term portfolio in 2021.

GlaxoSmithKline and Sanofi Stock Rally on EU Vaccine Deal

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
GlaxoSmithKline and Sanofi stock are rallying in early trading on Friday thanks to news they would supply the EU 300 million vaccine doses.

7 Coronavirus Vaccine Stocks to Watch as Approval Nears

By Thomas Niel, InvestorPlace Contributor
Whether or not we get an 'October Surprise' from President Donald Trump, these coronavirus vaccine stocks look hot now. AstraZeneca (NYSE:AZN) CureVac (NASDAQ:CVAC) GlaxoSmithKline (NYSE:GSK) Inovio (NASDAQ:INO) Johnson & Johnson (NYSE:JNJ) Moderna (NASDAQ:MRNA) Novavax (NASDAQ:NVAX)

5 Hot Stocks to Buy Still Profiting From Social Distancing

By Tezcan Gecgil, InvestorPlace Contributor
Although broader markets may continue to be volatilie in the rest of the year, these five hot stocks to buy should be on your shopping list.

5 High-Yield Drug Stocks That Are Undervalued With Great Upside

By Mark R. Hake, CFA
As the market continues to deal with the pandemic, these five cheap drug stocks have solid dividend yields of 4% and almost 37% upside.

3 Big Stock Charts for Friday: Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline

By David Moadel, InvestorPlace Contributor
Friday's big stock charts feature pharmaceutical-market names that recently posted terrific earnings data.

10 S&P 500 Stocks to Buy Increasing Their Dividends in 2020

By Will Ashworth, InvestorPlace Contributor
A number of S&P 500 companies have already increased their 2020 dividends by 10% or more. Here are 10 stocks to buy among this group. 

Amarin Has the Makings for a Gamechanging Product

By Tom Taulli, InvestorPlace Contributor
Amarin is targeting a huge market, and its main drug -- Vascepa -- is likely to be expanded in its coverage. Here’s a look at what’s ahead for the stock.

4 Stocks to Sell and 6 Stocks to Buy on Vaping Fears

By James Brumley, InvestorPlace Feature Writer
Turning Point Brands, Cronos Group and Altria are just some of the stocks to buy or sell here at a pivotal time for vaporizers.

5 Dividend Stocks to Buy From Across the Globe

By Aaron Levitt, InvestorPlace Contributor
With international dividend stocks, valuations are generally better and yields are bigger. Here are five stocks that stand out.
Load More